Recall of Quinapril

HPS Pharmacies wish to advise that multiple suppliers, in consultation with the Therapeutic Goods Administration (TGA), have initiated a drug recall for the following batches of quinapril products:

Quinapril GenericHealth 20mg (Batch: G106378)

APO-Quinapril 10mg  & 20mg (All batches)

Acquin^® 10mg & 20mg (All batches)

This recall is in addition to an earlier recall affecting Accupril^® and Accuretic^®, as follows:

This recall has been initiated following confirmation of the presence of the N-nitrosoquinapril impurity.

As a precautionary measure, sponsors of all marketed quinapril-containing tablets have  paused supply while the issue is investigated. Patients should be advised to speak to their prescriber as alternative treatment options may be required. Further information on this issue can be found on the TGA website.

Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF